8-K//Current report
Amylyx Pharmaceuticals, Inc. 8-K
Accession 0000950170-25-104546
$AMLXCIK 0001658551operating
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 7:03 AM ET
Size
377.0 KB
Accession
0000950170-25-104546
Documents
- 8-Kamlx-20250807.htmPrimary
8-K
- EX-99.1amlx-ex99_1.htm
EX-99.1
- GRAPHICimg212534189_0.jpg
GRAPHIC
- EX-101.SCHamlx-20250807.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-104546-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLamlx-20250807_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001658551
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 7:03 AM ET
- Size
- 377.0 KB